What will be presented is anyone's guess. However, I suspect the results will be positive. With GC touting a possible spinoff of the diagnostic division (by Q2 - if I recall), I just don't see how Lympro will/is not generating revenue for them very soon. Would be great if we get sales data or some sort of BP partnership on top of the Lympro data at the conference.